Delivery Order SPE2DB22D3011-SPE2DB25FQ2GB
- Not listed
- The Defense Logistics Agency awarded a $1,101.28 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mucinex D ER 1,200-120 mg tablets (24-count). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units) with a ceiling value of $1,467.93. This non-set-aside, firm fixed-price delivery order is scheduled for completion by June 3, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,016.35. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,472.20 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance is scheduled for completion by July 22, 2025, with fulfillment based at...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,295.32 for Mucinex D ER 600-60 mg tablets (18-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a $1,935.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units). The contract was executed without a set-aside designation, indicating competitive award under open procurement procedures. Performance will be completed by September 3, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $4,116.27. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,996.61 to AmerisourceBergen Drug Corp for the supply of Mucinex DM ER 600-30 mg tablets (20-count units) on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract employs firm fixed pricing and was awarded through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,680.12 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packaging) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilized firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract portfolio. The product will be delivered to the company's headquarters location in Conshohocken,...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2GBDelivery Order
The Defense Logistics Agency awarded a $1,928.50 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. Performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's comprehensive pharmaceutical distribution portfolio spans brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for over-the-counter cough and cold medication reflects the company's broad capability to fulfill diverse federal medical supply requirements through its expansive prime vendor agreement, which enables supply of pharmaceutical products and medical commodities to support military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/14/25 |